L J Beilin, B E Juel-Jensen. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Adrenergic alpha-Antagonists/administration & dosageAdrenergic beta-Antagonists/administration & dosageAdultBlood PressureBody WeightClinical Trials as TopicDrug AntagonismDrug CombinationsFemaleHumansHypertension/drug therapyHypotension, Orthostatic/etiologyMaleMiddle AgedPhenoxybenzamine/administration & dosagePhenoxybenzamine/adverse effectsPhysical ExertionPlacebosPosturePropranolol/administration & dosagePropranolol/adverse effectsPulse
Substances: See more » Adrenergic alpha-AntagonistsAdrenergic beta-AntagonistsDrug CombinationsPlacebosPhenoxybenzaminePropranolol
Year: 1972 PMID: 4112366 DOI: 10.1016/s0140-6736(72)91154-3
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321